United States Donates Life-Saving HIV/AIDS Antiretroviral Drugs to Trinidad and Tobago
The United States Government, through the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) Caribbean Regional Program, has handed over life-saving antiretroviral drugs to the Ministry of Health. Valued at USD$250,000, these drugs will support people living with HIV/AIDS in Trinidad and Tobago.
U.S. Chargé d’Affaires Dave Schnier in donating the medication to Health Minister Terrence Deyalsingh at the Ministry’s Port of Spain office said, “This donation reiterates the United States’ enduring commitment to support public health and to support people living with HIV/AIDS. The donation also reflects the strong and robust partnership between the U.S. government, the Ministry of Health, and the people of Trinidad and Tobago. It is our unified and shared goal to attain epidemic control and surpass the UNAIDS 95-95-95 goals.”
The Joint United Nations Program on HIV/AIDS (UNAIDS) launched the 95-95-95 targets in 2014 with the aim of diagnosing 95 percent of all HIV-positive individuals, providing antiretroviral therapy (ART) for 95 percent of those diagnosed, and achieving viral suppression for 95 percent of those treated by 2030.
The U.S. Embassy’s donation came as a result of a longstanding partnership between the Ministry of Health, the U.S. Centers for Disease Control and Prevention (CDC), the State Department Global AIDS Coordinator, and the U.S. Embassy.
Minister Deyalsingh in accepting the donation said, “This donation continues to cement and strengthen the unshakable bonds that exist between Trinidad and Tobago and the United States of America. The relationship is a strong one, it’s a good one, it’s a historical one, stretching back to pre-World War II days, when Trinidad and Tobago was a very important place in the fight in World War II. I thank you very much on behalf of Prime Minister Dr. Keith Rowley, the Cabinet, and the people, but most importantly, the community of people living with HIV for this donation. I assure you that these drugs will reach the intended target and have the intended outcome.”